Viewing Study NCT04446650


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2026-02-02 @ 3:50 AM
Study NCT ID: NCT04446650
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-21
First Post: 2020-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Myelofibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fedratinib View
None Myelofibrosis View
None Japanese View